S&P/ASX Index Rebalance Preview: Review Period Nearly Done; Big Impact Changes
There could be 30 changes for the ASX indices in September with a lot to trade for passive trackers. The adds have outperformed the deletes and...
376 Views
S&P/ASX Index Rebalance Preview: Potential Changes from Now to September
There could be 28 changes for the ASX indices in September with a lot to trade for passive trackers. The adds have outperformed the deletes by a...
403 Views
Australian Biotech Companies Amid Talk of Likely Interest Rate Cut
RBA keeps interest rates steady at 4.35%, while economists predict possible cut to 4.10% in 4Q24. Australian biotech companies should be in focus...
285 Views
Immutep (IMM): Lung May Jump Breast Cancer in Trial Queue
IMM reported positive headline data from its expanded TACTI-002 part A trial in first line (1L) non small cell lung cancer (NSCLC) at ASCO last week.
408 Views
Immutep Limited: Leading Not Lagging in Immuno-Oncology Development
Immutep Limited Leading not lagging in immuno-oncology development Immutep Limited (ASX:IMM) is a biotechnology company that is a leader in the...
1.1k Views